WHAT´S NEW in Spondyloarthritis?

In this section you will be able to identify the new content uploaded regularly .

Duration 6:31

Prof. William Tillett

Consultant rheumatologist, royal national hospital for rheumatic diseases senior lecturer, pharmacy and pharmacology, University of Bath, UK

" The Importance of addressing musculoskeletal signs & symptoms in psoriatic arthritis "

Duration 5:15

Prof. Eduardo Mysler

Director of the medical research organization, principal investigator and clinical protocol designer for medical institutions, OMI in Buenos Aires, Argentina

"The Role of JAKs in SpA "

Duration 7:15

Prof. Andrew Ostor

Consultant rheumatologist, Cabrini medical cente, and a Melbourne investigator, Emeritus research unit, Melbourne, Australia

"Unmet Needs in Axial SpA & PsA "

Duration 8:05

Prof. Philip Mease

Swedish medical center/ Providence St. Joseph Health and university of Washington, Seattle, Washington

"Upadacitinib for Active Psoriatic Arthritis Refractory to Biologics (SELECT-PSA 2)"

Duration 7:21

Prof. Ian Mclnnes

University of Glasgow

" Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

(SELECT-PSA 1)"

Duration 7:56

Prof. Desiree Van Der Heijde

Leiden University Medical Center, Leiden, The Netherlands

"Efficacy and Safety of Upadacitinib in a randomized, double-blind, placebo-controled,multicenter phase 2/3 clinical study of patients with active ankylosing spondylitis (SELECT-AXIS 1)"